Clarus Lifesciences III, L.P. - 30 Mar 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
10%+ Owner
Signature
CLARUS LIFESCIENCES III, L.P., By: Clarus Ventures III GP, L.P., its general partner, By: Blackstone Clarus III, L.L.C., its general partner, By: /s/ Omar Rehman, Name: Omar Rehman, Title: Chief Compliance Officer and Secretary
Issuer symbol
N/A
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
4
Filing time
01 Apr 2022, 17:30:25 UTC
Previous filing
20 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Other $0 -1,000,000 -30% $0.000000 2,375,037 30 Mar 2022 See Footnotes F1, F2, F4, F5, F6
holding IMGO Common Stock 61,695 30 Mar 2022 See Footnotes F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Clarus Lifesciences III, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects a pro rata distribution of shares of Common Stock to the partners of Clarus Lifesciences III, L.P., including 237,051 shares of Common Stock which were distributed to Clarus Ventures III GP, L.P., its general partner, which distributed such 237,051 shares of Common Stock shares to its partners.
F2 Reflects securities held directly by Clarus Lifesciences III, L.P. Clarus Ventures III GP, L.P. is the general partner of Clarus Lifesciences III, L.P. Blackstone Clarus III L.L.C. is the general partner of Clarus Ventures III GP, L.P. The sole member of Blackstone Clarus III L.L.C. is Blackstone Holdings II L.P.
F3 Reflects securities held directly by an investment fund affiliated with Clarus Lifesciences III, L.P., which received 61,695 shares of Common Stock in the distribution described above. Such investment fund may be deemed to be indirectly controlled by Blackstone Holdings II L.P.
F4 The general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is Blackstone Inc. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
F5 Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
F6 Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.